111 (NASDAQ:YI) Shares Down 1.1% – What’s Next?

111, Inc. Sponsored ADR (NASDAQ:YI) shares traded down 1.1% during trading on Wednesday . The company traded as low as $3.49 and last traded at $3.51. Approximately 5,615 shares were traded during trading, an increase of 92% from the average daily volume of 2,926 shares. The stock had previously closed at $3.55.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings raised 111 from a “sell (e+)” rating to a “sell (d-)” rating in a report on Friday, August 14th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock currently has a consensus rating of “Sell”.

111 Price Performance

The company has a market cap of $30.85 million, a price-to-earnings ratio of -2.51 and a beta of 0.67. The business’s 50-day simple moving average is $3.95 and its 200-day simple moving average is $5.67.

Insider Activity

In related news, Director Jian David Sun sold 115,440 shares of the company’s stock in a transaction that occurred on Wednesday, June 10th. The stock was sold at an average price of $0.22, for a total value of $25,396.80. Following the sale, the director owned 583,111 shares of the company’s stock, valued at approximately $128,284.42. This represents a 16.53% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last three months, insiders sold 595,540 shares of company stock worth $141,105. Insiders own 43.90% of the company’s stock.

111 Company Profile

111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.

111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.